Literature DB >> 20228286

A bibliometric review of cost-effectiveness analyses in the economic and medical literature: 1976-2006.

Dan Greenberg1, Allison B Rosen, Oren Wacht, Jennifer Palmer, Peter J Neumann.   

Abstract

BACKGROUND: Cost-effectiveness analysis (CEA) presenting a cost per quality-adjusted life year (QALY) ratio is frequently used to determine ''value for money'' in health care. Despite the proliferation of CEA research, there has been no detailed study focusing on the bibliometric properties of this literature.
OBJECTIVES: To describe and analyze trends in publications and coauthorship in the CEA literature from 1976 to 2006 and to identify the most prolific authors and research groups conducting CEAs.
METHODS: The authors used the Tufts Medical Center Registry of original CEAs published through 2006 (www.cearegistry.org). For each article, they recorded the year of publication, the journal title, and the number of contributing authors and their names. Authors were assigned credit based on their weighted contribution to the study (1 credit point for the first and last authors, (1/2) point for the second author, and ( 1)=(n) credit points for all other authors, where n reflects the number of coauthors).
RESULTS: Approximately 1400 CEAs presenting a cost/QALY ratio were published in 420 journals through 2006. The mean number of contributing authors was 4.7 +/- 2.4. Medical journals were characterized by a higher number of coauthors, as compared with the economic and health policy journals: 4.8 +/- 2.4 v. 4.2 +/- 2.0, P < 0.001. The lowest average number of coauthors was in Medical Decision Making (3.6) and the highest in the Journal of the American College of Cardiology (8.2). The most prolific authors were affiliated with Harvard and Tufts Universities and their affiliated hospitals. The authors identified 4 major research groups that contributed substantially to the field of cost-effectiveness analysis but did not find any substantial academic relationships across these groups.
CONCLUSIONS: The CEA literature continues to proliferate. Coauthorship trends appear to follow the rapid increase in the mean number of authors found in other publication types.

Mesh:

Year:  2010        PMID: 20228286     DOI: 10.1177/0272989X09360066

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  10 in total

1.  Integrating economic evaluation methods into clinical and translational science award consortium comparative effectiveness educational goals.

Authors:  Alexander Iribarne; Rachel Easterwood; Mark J Russo; Y Claire Wang
Journal:  Acad Med       Date:  2011-06       Impact factor: 6.893

2.  The use of cost-effectiveness analysis for pediatric immunization in developing countries.

Authors:  Cindy Low Gauvreau; Wendy J Ungar; Jillian Clare Köhler; Stanley Zlotkin
Journal:  Milbank Q       Date:  2012-12       Impact factor: 4.911

3.  Patterns of care in testicular torsion: influence of hospital transfer on testicular outcomes.

Authors:  Jenny H Yiee; Lynne Chang; Alan Kaplan; Lorna Kwan; Paul J Chung; Mark S Litwin
Journal:  J Pediatr Urol       Date:  2013-07-27       Impact factor: 1.830

4.  Coauthorship and institutional collaborations on cost-effectiveness analyses: a systematic network analysis.

Authors:  Ferrán Catalá-López; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Manuel Ridao; Máxima Bolaños; Anna García-Altés; Gabriel Sanfélix-Gimeno; Salvador Peiró
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

5.  Pharmaco-economic evaluation of antibiotic therapy strategies in DRG-based healthcare systems - a new approach.

Authors:  Michael H Wilke; R Grube
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

6.  The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.

Authors:  Yot Teerawattananon; Sripen Tantivess; Inthira Yamabhai; Nattha Tritasavit; Damian G Walker; Joshua T Cohen; Peter J Neumann
Journal:  Health Res Policy Syst       Date:  2016-12-03

Review 7.  When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.

Authors:  Ferrán Catalá-López; Gabriel Sanfélix-Gimeno; Manuel Ridao; Salvador Peiró
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

Review 8.  Global collaborative networks on meta-analyses of randomized trials published in high impact factor medical journals: a social network analysis.

Authors:  Ferrán Catalá-López; Adolfo Alonso-Arroyo; Brian Hutton; Rafael Aleixandre-Benavent; David Moher
Journal:  BMC Med       Date:  2014-01-29       Impact factor: 8.775

9.  Economic Evaluation in Global Perspective: A Bibliometric Analysis of the Recent Literature.

Authors:  Catherine Pitt; Catherine Goodman; Kara Hanson
Journal:  Health Econ       Date:  2016-02       Impact factor: 3.046

10.  Comparison of Economic Evaluation Methods Across Low-income, Middle-income and High-income Countries: What are the Differences and Why?

Authors:  Ulla Kou Griffiths; Rosa Legood; Catherine Pitt
Journal:  Health Econ       Date:  2016-01-17       Impact factor: 3.046

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.